DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ rallied 3.32% to $283.48 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.11% to 7,718.94 and Dow Jones Industrial Average falling 0.09% to 51,621.48.
AbbVie Inc. hit a new 52-week high, surpassing its previous peak of $283.43, which the company reached on October 13th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 2.13% to $253.91, Pfizer Inc. $(PFE)$ rose 2.96% to $29.21, and Amgen Inc. $(AMGN)$ rose 3.21% to $426.11.
Trading volume (5.6 M) eclipsed its 50-day average volume of 4.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 14, 2026.
Comments